Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-PD-1 Antibody with DC and NK Cells in Digestive Carcinoma
NCT05461235Phase 2Not yet recruiting
- Sponsor
- China Medical University
- Start
- Jul 2022
- Primary completion
- Jul 2025
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
01
Overview
A Phase 2 trial of autologous natural killer cells in gastrointestinal tumor, sponsored by China Medical University. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
autologous natural killer cells
03
Conditions
gastrointestinal tumor
Beyond the preview
Go deeper on NCT05461235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05461235.